Trial
NCT03712371
Study of Chitosan for Pharmacologic Manipulation of AGE Levels in Prostate Cancer Patients
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Medical University of South Carolina
Collaborators
—
Condition
Prostate Cancer
Intervention
Chitosan
Why stopped
Interim study results were not favorable to continue with further enrollment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-06-10